表紙
市場調査レポート

神経線維腫症:世界の治験動向

Neurofibromatoses Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 340876
出版日 ページ情報 英文 88 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
神経線維腫症:世界の治験動向 Neurofibromatoses Global Clinical Trials Review, H2, 2015
出版日: 2015年08月31日 ページ情報: 英文 88 Pages
概要

神経線維腫症は、神経系で腫瘍が成長する原因となる遺伝性疾患です。

当レポートでは、神経線維腫症の治験に関する最新動向について分析しており、各地域の主要国における治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 神経線維腫症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数

G7諸国での治験件数:遺伝性疾患治療薬の治験における神経線維腫症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:遺伝性疾患治療薬の治験における神経線維腫症の割合

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

神経線維腫症治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Novartis AG
    • AstraZeneca Plc
    • Pfizer Inc.
    • ZonMw
    • Sarcoma Alliance for Research through Collaboration
    • F. Hoffmann-La Roche Ltd.
    • 第一三共
    • Bayer AG
    • Array BioPharma Inc.
    • Arno Therapeutics, Inc.
  • 代表的な研究機関・病院の治験の概要
    • Indiana University
    • Massachusetts General Hospital
    • The Children's Hospital of Philadelphia
    • Assistance Publique - Hopitaux de Paris
    • Centre Hospitalier Universitaire de Nantes
    • Children's Oncology Group
    • Erasmus MC

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2842CTIDB

GlobalData's clinical trial report, "Neurofibromatoses Global Clinical Trials Review, H2, 2015" provides an overview of Neurofibromatoses clinical trials scenario. This report provides top line data relating to the clinical trials on Neurofibromatoses. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Neurofibromatoses
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Neurofibromatoses to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Neurofibromatoses to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Neurofibromatoses
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Neurofibromatoses Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • ZonMw
      • Clinical Trial Overview of ZonMw
      • Sarcoma Alliance for Research through Collaboration
      • Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Array BioPharma Inc.
      • Clinical Trial Overview of Array BioPharma Inc.
      • Arno Therapeutics, Inc.
      • Clinical Trial Overview of Arno Therapeutics, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Indiana University
      • Clinical Trial Overview of Indiana University
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • The Children's Hospital of Philadelphia
      • Clinical Trial Overview of The Children's Hospital of Philadelphia
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Centre Hospitalier Universitaire de Nantes
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Nantes
      • Children's Oncology Group
      • Clinical Trial Overview of Children's Oncology Group
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Neurofibromatoses Therapeutics, Global, Clinical Trials by Region, 2015*
  • Neurofibromatoses Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Neurofibromatoses Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Neurofibromatoses to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Neurofibromatoses Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Neurofibromatoses Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Neurofibromatoses to Genetic Disorders Clinical Trials, E7 Countries (%), 2015*
  • Neurofibromatoses Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Neurofibromatoses Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Neurofibromatoses Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Neurofibromatoses Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Neurofibromatoses Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Neurofibromatoses Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Neurofibromatoses Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by ZonMw, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Array BioPharma Inc., 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Arno Therapeutics, Inc., 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nantes, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015*

List of Figures

  • Neurofibromatoses Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Neurofibromatoses Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Neurofibromatoses Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Neurofibromatoses to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Neurofibromatoses Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Neurofibromatoses Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Neurofibromatoses to Genetic Disorders Clinical Trials, E7 Countries (%), 2015*
  • Neurofibromatoses Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Neurofibromatoses Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Neurofibromatoses Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Neurofibromatoses Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Neurofibromatoses Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top